BACKGROUND: The importance of changes in the supporting tumor stroma for cancer initiation and progression is well established. The characteristics of an activated tumor stroma, however, are not completely understood. In an effort to better characterize the desmoplastic response to human skin tumors, we evaluated the expression pattern of three stromal cell markers, fibroblast-activation protein (FAP), endoglyx-1, and endosialin, in a series of melanocytic and epithelial skin tumors. METHODS: Immunohistochemistry using antibodies against FAP, endoglyx-1, and endosialin was carried out in skin samples obtained from 43 patients. Furthermore, microarray data from an independent set of human skin cancers were analyzed. RESULTS: FAP-positive fibroblasts were detected in all tumor tissues tested, including cases of melanocytic nevi, melanoma metastases, basal cell carcinomas, and squamous cell carcinomas. In cutaneous melanoma metastases, we identified different compartments within the stromal response on the basis of the regions of FAP expression. Endoglyx-1 expression was confined to normal and tumor blood vessel endothelium including 'hot spots' of neoangiogenesis within the cutaneous melanoma metastases. Endosialin was selectively induced in subsets of small- and medium-sized tumor blood vessels in melanoma metastases and squamous cell carcinomas. CONCLUSIONS: These data describe novel aspects of stromal marker expression in distinct compartments of human skin tumors and may point to potential targets for novel therapeutic strategies aimed at the tumor stroma.
BACKGROUND: The importance of changes in the supporting tumor stroma for cancer initiation and progression is well established. The characteristics of an activated tumor stroma, however, are not completely understood. In an effort to better characterize the desmoplastic response to humanskin tumors, we evaluated the expression pattern of three stromal cell markers, fibroblast-activation protein (FAP), endoglyx-1, and endosialin, in a series of melanocytic and epithelial skin tumors. METHODS: Immunohistochemistry using antibodies against FAP, endoglyx-1, and endosialin was carried out in skin samples obtained from 43 patients. Furthermore, microarray data from an independent set of humanskin cancers were analyzed. RESULTS:FAP-positive fibroblasts were detected in all tumor tissues tested, including cases of melanocytic nevi, melanoma metastases, basal cell carcinomas, and squamous cell carcinomas. In cutaneous melanoma metastases, we identified different compartments within the stromal response on the basis of the regions of FAP expression. Endoglyx-1 expression was confined to normal and tumor blood vessel endothelium including 'hot spots' of neoangiogenesis within the cutaneous melanoma metastases. Endosialin was selectively induced in subsets of small- and medium-sized tumor blood vessels in melanoma metastases and squamous cell carcinomas. CONCLUSIONS: These data describe novel aspects of stromal marker expression in distinct compartments of humanskin tumors and may point to potential targets for novel therapeutic strategies aimed at the tumor stroma.
Authors: J Humberto Treviño-Villarreal; Douglas A Cotanche; Rosalinda Sepúlveda; Magda E Bortoni; Otto Manneberg; Taturo Udagawa; Rick A Rogers Journal: J Histochem Cytochem Date: 2011-12 Impact factor: 2.479
Authors: Brian Tomkowicz; Katherine Rybinski; Brian Foley; Wolfgang Ebel; Brad Kline; Eric Routhier; Philip Sass; Nicholas C Nicolaides; Luigi Grasso; Yuhong Zhou Journal: Proc Natl Acad Sci U S A Date: 2007-11-06 Impact factor: 11.205
Authors: Beverly A Teicher; Rebecca G Bagley; Cecile Rouleau; Ariel Kruger; Yi Ren; Leslie Kurtzberg Journal: Ann Saudi Med Date: 2011 Mar-Apr Impact factor: 1.526
Authors: Sandra P D'Angelo; Omid A Hamid; Ahmad Tarhini; Dirk Schadendorf; Bartosz Chmielowski; Frances A Collichio; Anna C Pavlick; Karl D Lewis; Susan C Weil; John Heyburn; Charles Schweizer; Daniel J O'Shannessy; Richard D Carvajal Journal: Invest New Drugs Date: 2017-11-11 Impact factor: 3.651
Authors: Eiji Kiyohara; Nicholas Donovan; Ling Takeshima; Sharon Huang; James S Wilmott; Richard A Scolyer; Peter Jones; Elizabeth B Somers; Daniel J O'Shannessy; Dave S B Hoon Journal: Cancer Microenviron Date: 2015-06-18
Authors: Daniel J O'Shannessy; Elizabeth B Somers; Lakshmi K Chandrasekaran; Nicholas C Nicolaides; Jennifer Bordeaux; Mark D Gustavson Journal: Oncotarget Date: 2014-06-30
Authors: A Ohradanova; K Gradin; M Barathova; M Zatovicova; T Holotnakova; J Kopacek; S Parkkila; L Poellinger; S Pastorekova; J Pastorek Journal: Br J Cancer Date: 2008-09-23 Impact factor: 7.640
Authors: Sahana Suresh Babu; Yanet Valdez; Andrea Xu; Alice M O'Byrne; Fernando Calvo; Victor Lei; Edward M Conway Journal: BMC Cancer Date: 2014-02-20 Impact factor: 4.430